IBT Wujiang Technology
IBT无疆科技
IBT Wujiang Technology (IBT无疆科技) is a digital therapeutics company focused on brain science research and central nervous system disease intervention. As of late 2021, it had completed three funding rounds within its first year of operation, with total raised exceeding 100 million RMB .
The company's Pre-A+ round in December 2021 was co-led by Legend Star and Heyu Capital, with existing investors Source Code Capital—which had led the Pre-A round—and Linear Capital following on . Source Code Capital continued to increase its stake across multiple rounds .
AI-generated — may contain errors, please verify.
Coverage
MaHui Founder | The Moment Your Emotions "Light Up" Could Reach 2 Million Children with Autism
"Emoji Donation" Builds China's Professional "Emoji Database"
Taichi Graphics Raises $50 Million in Series A Funding Led by Source Code Capital
Dedicated to empowering every ordinary person to create their own digital world.
Source Code Capital portfolio company Silicon Integrated announced the completion of a Series D funding round worth several hundred million yuan, with existing investor Source Code Capital continuing to increase its stake.
An innovative chip design company with independent, self-developed intellectual property.
AI Medical Device Company "Silicon Based Bionics" Raises Over 800 Million Yuan in Three C-Round Tranches, Led by Source Code Capital
China's first CGM company to receive regulatory approval and achieve mass production without requiring finger-prick calibration
AI-powered molecular simulation company **DeepWise** announced the completion of a Series B funding round of tens of millions of dollars, co-led by **Source Code Capital**.
Building a next-generation microscale industrial design platform to unlock R&D and manufacturing productivity across the industry.
Source Code Capital portfolio company Standard Robots announced the completion of a Pre-C funding round worth several hundred million RMB, with existing shareholder Source Code Capital continuing to increase its stake.
Based on the "WIPE" strategy, targeting the global market.
Digital therapeutics company IBT无疆科技 announced the completion of its Pre-A+ funding round, with existing investor Source Code Capital continuing to increase its stake.
Advancing the Commercialization of Next-Generation Digital Therapeutics
